ISPE, the International Society for Pharmaceutical Engineering, has released a new Cultural Excellence Report announced at its Conference on Quality Culture and Quality Metrics.
Cultural excellence recognises quality not as an operational burden or compliance requirement, but as a necessity that allows companies to make decisions that are in the best interest of the patient.
The ISPE Cultural Excellence Report shares the vision of quality culture improvements across six dimensions and outlines a series of practical and powerful approaches, practices and tools to support implementation of the cultural excellence framework, and promote behavioural change that will benefit the patient.
The assessment
The Cultural Excellence Report concentrates on six dimensions of cultural excellence: Leadership and Vision, Mindset and Attitudes, Gemba Walk, Leading Quality Indicators and Triggers, Oversight and Review and Structural Enablers.
The ISPE Quality Culture Subteam prepared the corporate culture gap analysis from the ISPE Drug Shortage Assessment and Prevention Tool to establish a set of 21 desired key behaviours that support the six dimensions of cultural excellence.
The assessment tool featured in the report was designed to help organisations assess the maturity of these behaviours as part of their quality culture programme.
The report is available in PDF format and is $49 for nonmembers.
